Outcomes of extremely low birth weight infants given early high-dose erythropoietin
Authors:
Open Access
- 21 June 2012
- journal article
- research article
- Published by Springer Nature in Journal of Perinatology
- Vol. 33 (3) , 226-230
Abstract
Objective: To evaluate long-term outcomes of 60 extremely low birth weight (ELBW) infants treated with or without three injections of high-dose erythropoietin (Epo). Study Design: A retrospective analysis of anthropometric and neurodevelopmental outcome data comparing 30 ELBW infants enrolled in a phase I/II study examining the pharmacokinetics of high-dose Epo (500, 1000 and 2500 U/kg × 3 doses) administered to 30 concurrent controls. Result: Birth characteristics and growth from 4 to 36 months were similar for untreated and Epo-treated patients. Multiple linear regression analysis of neurodevelopmental follow-up scores from 17/25 Epo-treated and 18/26 control infants identified that Epo correlated with improvement of cognitive (R=0.22, P=0.044) and motor (R=0.15, P=0.026) scores. No negative long-term effects of Epo treatment were evident. Conclusion: Retrospective analysis of the only available long-term follow-up data from ELBW infants given high-dose Epo treatment suggests that Epo treatment is safe and correlates with modest improvement of neurodevelopmental outcomes.Keywords
This publication has 29 references indexed in Scilit:
- Comparison of the Bayley II Mental Developmental Index and the Bayley III cognitive scale: are we measuring the same thing?Acta Paediatrica, 2011
- Erythropoietin for neonatal brain injury: opportunity and challengeInternational Journal of Developmental Neuroscience, 2011
- Human Recombinant Erythropoietin in Asphyxia Neonatorum: Pilot TrialPediatrics, 2010
- Erythropoietin promotes hippocampal neurogenesis in in vitro models of neonatal strokeNeurobiology of Disease, 2010
- Erythropoietin improves neurodevelopmental outcome of extremely preterm infantsAnnals of Neurology, 2010
- Systemic injection of recombinant human erythropoietin after focal cerebral ischemia enhances oligodendroglial and endothelial progenitor cells in rat brainAnatomy & Cell Biology, 2010
- Seven-month developmental outcomes of very low birth weight infants enrolled in a randomized controlled trial of delayed versus immediate cord clampingJournal of Perinatology, 2009
- Recent trends in erythropoietin‐mediated neuroprotectionInternational Journal of Developmental Neuroscience, 2007
- Neonatal Hypoxia/Ischemia Is Associated With Decreased Inflammatory Mediators After Erythropoietin AdministrationStroke, 2005
- Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gmThe Journal of Pediatrics, 1978